(From DNA India). The Indian group Reliance Life Sciences is a well-backed portion of a large conglomerate, and is forging ahead with stem cell research for regenerative medicine - Indian bureaucrats haven't developed anything as monumentally harmful to progress as the FDA in the US. "RLS also has plans to introduce therapies for cardiac and nerve-related diseases like Alzheimer's and Parkinson's. ... They are under pre-clinical stages and we are awaiting approval for human trials from the department of biotechnology (DBT) ... The efficacy of the therapies for neuro-degenerative diseases like Parkinson's and Alzheimer's has been successfully identified in pre-clinical trials ... The stem cell therapy developed by Reliance for the treatment of cartilage damage associated with osteoarthritis is under research studies and will soon enter the pre-clinical studies."
18
Jun
2006
Update on Reliance Life Sciences
Comments
Post a comment; thoughtful, considered opinions are valued. Please note that comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.
First Steps
The Causes of Aging
- Accumulating AGEs
- Buildup of Amyloid Between Cells
- The Failing Adaptive Immune System
- The Failing Innate Immune System
- Declining Lysosomal Function
- Mitochondrial DNA Damage
- Nuclear DNA Damage
- Buildup of Senescent Cells
- Other Causes of Aging
Archives and Feeds
- Monthly News and Blog Archives
- Newsletter Archive
- Using the Fight Aging! Content Feeds
- Fight Aging! on the Kindle
Required Reading
- Calorie Restriction
- The Community, Visualized
- Cryonics
- Engineered Negligible Senescence
- Envisaging a World Without the FDA
- How to Argue for Longevity Science
- Introductory Articles
- The Odds of Human Longevity Mutations
- The Need For Activism and Advocacy
- Stem Cells, Regenerative Medicine
- Twelve Ways to Extend Mouse Life Span
- Transhumanism and Human Longevity
- The Vital Debate in Aging Research
- What is Anti-Aging?
Creative Commons
- All of Fight Aging!, with the exception of the introductory articles, is published under the Creative Commons Attribution 3.0 license. In short, this means that you are encouraged to republish and rewrite Creative Commons licensed Fight Aging! content in any way you see fit, the only requirements being that you (a) link to the original, (b) attribute the author, and (c) attribute Fight Aging!.